Atractylenolide III inhibits epithelial-mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway

Compared with the available drugs for the treatment of fibrosis in other organs, the development of intestinal anti-fibrosis drugs is limited. Therefore, it is of practical significance to examine novel drugs to delay or block the development of intestinal fibrosis. The present study aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Mingjin, Jiang, Wenwen, Luo, Chunli, Yang, Min, Ren, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809054/
https://www.ncbi.nlm.nih.gov/pubmed/35088892
http://dx.doi.org/10.3892/mmr.2022.12614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809054/
https://www.ncbi.nlm.nih.gov/pubmed/35088892
http://dx.doi.org/10.3892/mmr.2022.12614

Ejemplares similares